Respiratory Devices Market to Surge beyond US$ 32.3 Billion by 2025

Image Credit : foresight

The major factor driving growth of the respiratory devices market include INCREASING prevalence of respiratory diseases such as COPD and asthma, increasing respiratory disease with rise in pollution level and rising geriatric population. According to the study by Global Burden of Disease, 2016, an estimated around 251 million cases of COPD were reported worldwide. According to the World Health Organization (WHO), 2015, an estimated 3.17 million deaths were caused by the disease accounting for 5% of all deaths. However, lack of awareness regarding the diseases harmful effects of certain respiratory care devices on neonates are the factors restraining respiratory devices market growth.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1299

Respiratory devices or equipment are commonly used in the medical settings as per the medical condition. Ventilators are the most common tools, which are commonly used in emergency medicine and long-term critical care. In addition to the therapeutic respiratory devices, the diagnostic and monitoring devices minimize hospitalizations, thereby lowering the cost associated with medical settings.

Increasing admissions of critical care patients in Intensive Care Units (ICU) is expected to fuel the market growth

Increasing prevalence of chronic respiratory diseases such as asthma, chronic pulmonary lung disease, pulmonary hypertension, and occupational lung disease are the major factors augmenting growth of the respiratory devices market, owing to the pronounced need of therapeutic respiratory devices in the medical as well as in the homecare settings. According to the World Health Organization (WHO), in 2017, asthma is a major non communicable disease with an estimated 235 million people suffering from the condition. According to the American Academy of Allergy Asthma and Immunology, 2015, an estimated number of people suffering from asthma is expected to increase by more than 100 million by 2025. North America is expected to dominate the respiratory devices market, owing to increasing number of hospitalizations and emergency visits associated with acute or life threatening medical problems. According to the study by Society of Critical Care Medicine 2016, more than 5.7 million patients are admitted annually to intensive care units (ICUs) in the U.S. for support of airway, breathing or circulation, and comprehensive management of injury. Also, According to the Centers of Disease Control and Prevention (CDC), 2017, around 1.7 million emergency department visits with chronic and unspecified bronchitis were registered in the U.S. hospital facilities. However, stringent FDA approvals, lack of awareness about innovative devices and unaffordable or high cost of respiratory devices are the factors restraining growth of the respiratory devices market.

Increasing support from international organizations for prevention of chronic respiratory diseases is expected to accelerate the market growth

Various organizations, institutions, and agencies are working towards improving the diagnosis and the medical care needed to reduce the global burden of respiratory diseases. For instance, the Global Alliance against Chronic Respiratory Diseases (GARD) was formed with the support from the World Health Organization (WHO) to control chronic respiratory diseases. GARD is a voluntary alliance of national, international organizations, and agencies from many economies. The main objective of GARD is to develop simple and affordable strategies for chronic respiratory diseases (CRD) and to encourage economies to implement health promotion and CRD prevention policies. Also, increasing birth defects such as newborn respiratory distress syndrome, cyanosis, and Broncho-pulmonary dysplasia requires the need for neonate/pediatric respiratory devices to increase the survival chances of infants. According to the Centers of Disease Control and Prevention (CDC), an estimate of 1.5 million babies were born with birth defects with about one quarter primary consultations related to respiratory complaints.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1299

The major players operating the global respiratory devices market include Koninklijke Philips N.V., 3M, AstraZeneca Plc., GE Healthcare, GlaxoSmithKline Plc., Medtronic plc, Becton, Dickinson and Company, Invacare Corporation, ResMed, Inc., and CareFusion Corporation.

You may be interested

Increasing funding in gene therapies is expected to fuel the growth of viral vectors and plasmid DNA manufacturing market
Healthcare
Healthcare

Increasing funding in gene therapies is expected to fuel the growth of viral vectors and plasmid DNA manufacturing market

Albert R - April 25, 2018

Gene therapy and genetically modified therapies are promising treatment option, which includes introduction of a normal or functional copy of a gene in the defective cell. Gene…

Increasing incidence of cancer is expected to fuel the growth of cancer metabolism based therapeutics market
Healthcare
Healthcare

Increasing incidence of cancer is expected to fuel the growth of cancer metabolism based therapeutics market

Albert R - April 25, 2018

According to the American Cancer Society (ACS), approximately 53,670 people are expected be diagnosed with pancreatic cancer and approximately 43,090 people are expected to die due to…

Innovation in technology to combat infectious diseases is expected to drive the future meningitis treatment market
Healthcare
Healthcare

Innovation in technology to combat infectious diseases is expected to drive the future meningitis treatment market

Albert R - April 25, 2018

Major driving factor for growth of the meningitis treatment market include the alliance of public and private sectors to increase availability of vaccine to the populace. For…

Most from this category